Paying for Prescription Drugs in the New Administration

JAMA. 2021 Mar 2;325(9):819-820. doi: 10.1001/jama.2021.0009.

Authors

Aaron S Kesselheim¹, Thomas J Hwang¹, Jerry Avorn¹

Affiliation

¹ Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

PMID: 33651097
DOI: 10.1001/jama.2021.0009

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Drug Costs / legislation & jurisprudence*
Humans
Legislation, Drug
Medicare / legislation & jurisprudence
Prescription Drugs / economics*
Prescription Fees / legislation & jurisprudence*
United States

Substances

Prescription Drugs